Abstract:Abstract STUDY QUESTION Which independent factors influence intracytoplasmic sperm injection (ICSI) outcomes in patients with complete azoospermia factor c (AZFc) microdeletions? SUMMARY ANSWER In patients with complete AZFc microdeletions, the sperm source, male luteinizing hormone (LH), the type of infertility in women, and maternal age are the independent factors associated with ICSI outcomes. WHAT IS KNOWN ALREADY AZF microdeletions are the second most prevalent factor contributing to infertility in men, with AZFc microdeletions being the most frequently affected locus, accounting for 60% to 70% of all cases. The primary clinical phenotypes are oligoasthenozoospermia and azoospermia in patients with complete AZFc microdeletions. These patients can achieve paternity through ICSI using either testicular (T-S) or ejaculated (E-S) spermatozoa. With aging in men with AZFc microdeletions, oligoasthenozoospermia or severe oligozoospermia may gradually progress to azoospermia. STUDY DESIGN, SIZE, DURATION In this retrospective cohort study, the independent factors associated with the outcomes of 634 ICSI cycles in 634 couples with the transfer of 1,005 embryos were evaluated between February 2015 and December 2023. The analysis included 398 ICSI cycles in 398 couples using E-S and 236 ICSI cycles in 236 couples using T-S; all men had complete AZFc microdeletions. PARTICIPANTS/MATERIALS, SETTING, METHODS The inclusion criteria were as follows: 1) men had complete AZFc microdeletions and 2) the couple underwent ICSI treatment using T-S or E-S. The exclusion criteria were as follows: 1) cycles involving frozen-thawed oocytes; 2) cycles in which all fresh embryos were frozen and not transferred; 3) cycles lost to follow-up; and 4) multiple ICSI cycles, apart from the first cycle for each couple. The primary outcome was the cumulative live birth rate per ICSI cycle, whereas the secondary outcomes were the clinical pregnancy rate per ICSI cycle, fertilization rate and the no-embryo-suitable-for-transfer cycle rate (NESTR). Moreover, the maternal and neonatal outcomes were analyzed. Continuous variables showing non-normal distributions were expressed as median and interquartile range (IQR) and were analyzed using the Kruskal-Wallis test. Categorical variables were expressed as percentages and were analyzed using the χ2 or Fisher’s exact test. Linear and logistic regression models were constructed to assess the independent factors associated with ICSI outcomes. MAIN RESULTS AND THE ROLE OF CHANCE The T-S group exhibited inferior ICSI outcomes than the E-S group, marked by significantly reduced rates of cumulative live birth, clinical pregnancy, fertilization, high-quality embryo, blastocyst formation and implantation, with a higher NESTRs. However, the miscarriage rate and neonatal outcomes did not significantly differ between the groups. Multivariate linear regression analysis demonstrated that reduced fertilization rates were significantly associated with T-S use (adjusted β, -0.281; 95% confidence interval (CI), -0.332 to -0.229). Multivariate logistic regression demonstrated that increased NESTRs were significantly associated with T-S use (adjusted odds ratio (OR), 4.204; 95% CI, 2.340–7.691), along with uterine anomaly in women (adjusted OR, 2.853; 95% CI, 1.053–7.718), infertility in women with multiple etiologies (adjusted OR, 11.118; 95% CI, 2.034–66.508) and advanced maternal age (adjusted OR, 1.138; 95% CI, 1.029–1.263). The use of T-S (adjusted OR, 0.318; 95% CI, 0.188–0.528), uterine anomaly in women (adjusted OR, 0.263; 95% CI, 0.058–0.852) and increased maternal age (adjusted OR, 0.877; 95% CI, 0.801–0.958) were also associated with decreased clinical pregnancy rates per ICSI cycle. Likewise, lower cumulative live birth rates were associated with T-S use (adjusted OR, 0.273; 95% CI, 0.156–0.468), male LH levels (adjusted OR, 0.912; 95% CI, 0.837–0.990), uterine anomaly (adjusted OR, 0.101; 95% CI, 0.005–0.529), and increased maternal age (adjusted OR, 0.873; 95% CI, 0.795–0.958). No significant differences were observed in the maternal and neonatal outcomes between both groups. LIMITATIONS, REASONS FOR CAUTION The study was based on a single-centre, retrospective cohort design. The molecular diagnosis of AZFc microdeletions was reliant on loci sY254 and sY255 according to the European Academy of Andrology and European Molecular Genetics Quality Network guidelines. While our findings were based on the clinical phenotypes and laboratory parameters, the abnormalities in the genetic profiles of spermatogenesis and early embryonic development in patients between the T-S and E-S groups have not yet been elucidated. WIDER IMPLICATIONS OF THE FINDINGS Our results offer important insights into the independent factors that influence ICSI outcomes in patients with complete AZFc microdeletions. ICSI using E-S is a more favourable therapeutic option for younger patients with AZFc microdeletions and with sperm present in their ejaculate. This study highlights a new direction to investigate the molecular and phenotypic differences between the T-S and E-S groups, which may contribute to the diagnosis and treatment of complete AZFc microdeletions. STUDY FUNDING/COMPETING INTERESTS This study was supported by Capital’s Funds for Health Improvement and Research (2022-2-4094), Beijing Natural Science Foundation (7232203, 7242164), National Key Research and Development Program (2021YFC2700200, 2023YFC2705600), National Natural Science Foundation of China (82301889), Peking University Third Hospital Innovation Transformation Fund (BYSYZHKC2023103), Peking University Third Hospital Clinical Cohort Construction Project (BYSYDL2023016), and Young Elite Scientists Sponsorship Program by CAST (2023QNRC001). None of the authors have any competing interests to declare. TRIAL REGISTRATION NUMBER N/A

Association of Cystic Fibrosis Transmembrane-Conductance Regulator Gene Mutation with Negative Outcome of Intracytoplasmic Sperm Injection Pregnancy in Cases of Congenital Bilateral Absence of Vas Deferens.

Genetic diagnosis and outcomes of intracytoplasmic sperm injection in South Chinese patients with congenital bilateral aplasia of the vas deferens

Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression Rate in Healthy Spermatozoa is Not Correlated with Ovum Fertilisation Rate.

[Detection of pathogenic gene mutations in thirteen cases of congenital bilateral absence of vas deferens infertility patients]

Compound Heterozygous Variants in CFTR with Potentially Reducing ATP‐binding Ability Identified in Chinese Infertile Brothers with Isolated Congenital Bilateral Absence of Vas Deferens

Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) in Chinese patients with congenital bilateral absence of vas deferens

A Novel Hemizygous Loss-of-function Mutation in ADGRG2 Causes Male Infertility with Congenital Bilateral Absence of the Vas Deferens

Re: Poor Intracytoplasmic Sperm Injection Outcome in Infertile Males with Azoospermia Factor C Microdeletions Editorial Comment

Compound heterozygous mutations in CFTR causing congenital bilateral absence of the vas deferens in a Chinese pedigree

The Association Between Variants in the CFTR Gene and Nonobstructive Male Infertility: A Meta‐analysis

Poor intracytoplasmic sperm injection outcome in infertile males with azoospermia factor c microdeletions

The association between the two more common genetic causes of spermatogenic failure: a 7-year retrospective study

Novel Mutations and Polymorphisms in the CFTR Gene Associated with Three Subtypes of Congenital Absence of Vas Deferens.

Phenotypic impact of CFTR mutations on male reproductive tract agenesis in a Chinese cohort with congenital absence of the vas deferens

Intracytoplasmic Sperm Injection Versus Conventional In-Vitro Fertilisation for Couples with Infertility with Non-Severe Male Factor: a Multicentre, Open-Label, Randomised Controlled Trial

Independent Factors Associated with Intracytoplasmic Sperm Injection Outcomes in Patients with Complete Azoospermia Factor C Microdeletions

Complex uterine cavity abnormalities increase the risk of miscarriage in in vitro fertilization/intracytoplasmic sperm injection in fresh cycle-assisted pregnancies

An isoperimetric inequality for a nonlinear eigenvalue problem

Clinical Review#: State of the art for genetic testing of infertile men

Multiple criteria in sonographic diagnosis of prostatic carcinoma allows identification of all glands harboring clinically significant tumor: an in vitro study with histopathologic correlation

Endometrial cavity fluid is associated with deleterious pregnancy outcomes in patients undergoing in vitro fertilization/intracytoplasmic sperm injection: a retrospective cohort study